KemPharm EPS beats by $0.02, misses on revenue

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

KemPharm EPS beats by $0.02, misses on revenue

To read the full story on Seeking Alpha, click here.

KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From Mar 2024 to May 2024

Click Here for more KemPharm Charts.

KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more KemPharm Charts.

KemPharm Inc News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 29 April 2024 (1 day ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 11 April 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 10 April 2024 (3 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 9 April 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 4 April 2024 (4 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Thursday 4 April 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 2 April 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 1 July 2023 (10 months ago) • Edgar (US Regulatory)

More KemPharm Inc News Articles

Sterling vs AUD

Verizon Communications

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions